In addition, studies have shown that YAP1 can inhibit the activity of GSK3β, regulate the subcellular location and increase transcriptional activity of β-catenin to promote the proliferation of GBM cells (Wang et al., 2017). The gene discussed is GSK3B; the disease is glioblastoma.